Recent Security Class Actions

Centessa Pharmaceuticals plc American Depositary Shares (NASDAQ: CNTA)

1 Day left to seek lead plaintiff status.

Company Name:Centessa Pharmaceuticals plc American Depositary Shares
Stock Symbol:NASDAQ: CNTA
Class Period Start:05/28/2021
Class Period End (inclusive):06/01/2022
Filing Deadline:11/28/2022

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) lixivaptan, the Company’s drug product, was less safe than the Company had represented; (ii) the Company overstated lixivaptan’s clinical effectiveness and commercial viability; (iii) ZF874, another of the Company’s drug products,  was less safe than the Company had represented; (iv) the Company overstated ZF874’s clinical effectiveness and commercial viability while downplaying the drug’s safety issues; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Centessa Pharmaceuticals plc American Depositary Shares (NASDAQ: CNTA) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.